Molecular variants of epidermal growth factor in malignant astrocytoma

R. K. Rao, M. Shantaram, A. R. Aroor, A. Raja, T. P. Davis, A. Rao

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


The present study has measured EGF levels in primary brain tumor tissues. EGF levels were measured by specific radioimmunoassay (RIA) and further analyzed by reversed-phase high performance liquid chromatography (RP-HPLC) followed by RIA and radioreceptor binding. The levels of EGF-like immunoreactivity (EGF-LI) in astrocytoma-IV tumors were fourfold greater than those in normal brain tissues. In astrocytoma-II and astrocytoma-III tumors, however, levels of EGF-LI were not different from those in normal brain. HPLC analysis of extracts from normal brain tissue and astrocytoma-II showed one peak of EGF-LI that coeluted with standard human EGF (retention time 22 min). Interestingly, EGF-LI in extracts of astrocytoma-IV tumors eluted in two distinct peaks with retention times of 24 and 26 min (Astro-A and Astro-B, respectively). Materials in both Astro-A and Astro-B peaks reduced the specific binding of [125I]hEGF to EGF receptors in human placental membranes. These studies demonstrate elevated levels of EGF-LI in malignant astrocytoma, but not in benign tumors. Furthermore, two different EGF-like molecules that are different from native EGF are present in malignant astrocytoma.

Original languageEnglish (US)
Pages (from-to)179-181
Number of pages3
Issue number1
StatePublished - 1996


  • Brain
  • Cancer
  • EGF
  • Human
  • Receptor
  • Transformation
  • Tumor

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Endocrinology
  • Cellular and Molecular Neuroscience


Dive into the research topics of 'Molecular variants of epidermal growth factor in malignant astrocytoma'. Together they form a unique fingerprint.

Cite this